Skip to main content

Peer Review reports

From: Evaluation and comparison of efficacy and safety of tirzepatide, liraglutide and SGLT2i in patients with type 2 diabetes mellitus: a network meta-analysis

Original Submission
27 Jul 2024 Submitted Original manuscript
4 Aug 2024 Reviewed Reviewer Report
4 Sep 2024 Reviewed Reviewer Report
28 Oct 2024 Reviewed Reviewer Report
11 Nov 2024 Author responded Author comments - Xiaoping Yang
Resubmission - Version 2
11 Nov 2024 Submitted Manuscript version 2
15 Nov 2024 Author responded Author comments - Xiaoping Yang
Resubmission - Version 3
15 Nov 2024 Submitted Manuscript version 3
18 Nov 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
9 Dec 2024 Editorially accepted
24 Dec 2024 Article published 10.1186/s12902-024-01805-z

You can find further information about peer review here.

Back to article page